Question 1

What’s the financial overview for Innate Pharma S.A.?

Accepted Answer

Innate Pharma S.A.’s market cap stands at $0.00 trillion right now. The company’s trailing twelve-month earnings per share EPS is $-0.71, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Innate Pharma S.A. Stock ROE tell us?

Accepted Answer

Innate Pharma S.A. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for Innate Pharma S.A.?

Accepted Answer

The Innate Pharma S.A. stock per share price is $2.06.

Innate Pharma S.A.

Unlock 25+ Years of Financial Data

Frequently Asked Questions

What’s the financial overview for Innate Pharma S.A.?

How can I analyze historical data?

What does Innate Pharma S.A. Stock ROE tell us?

What is per share price for Innate Pharma S.A.?